OSI Pharmaceuticals (OSIP) - formerly Oncogene Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (118)	8/24/2000 7:52:12 AM
From: Micawber	of 447

August 24, 2000 Biotech Industry Flexes New Muscle Investors Pump Cash Into Research By ANDREW POLLACK As a young biotechnology company in 1986, OSI Pharmaceuticals agreed to use its expertise in genes and molecular biology to help Pfizer Inc. discover new drugs for cancer. As in many such deals, OSI agreed to receive a royalty of about 5 percent on the sales of any drugs that made it to market. nytimes.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next